MA02.05 a Double-Blind, Randomized, Placebo-Controlled Phase 3 Noninferiority Study of Darbepoetin Alfa for Anemia in Advanced NSCLC

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.325
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

MA02.06 a Randomized, Double-Blind, Placebo-Controlled Trial of Chemotherapy Combined With Yangzheng Xiaoji in Advanced NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Etanercept in Alzheimer Disease: A Randomized, Placebo-Controlled, Double-Blind, Phase 2 Trial

Neurology
Neurology
2015English

Efficacy of Pregabalin in Post-Traumatic Peripheral Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial

Journal of Neurology
Neurology
2018English

Becaplermin Gel in the Treatment of Pressure Ulcers: A Phase II Randomized, Double-Blind, Placebo-Controlled Study

Wound Repair and Regeneration
DermatologySurgery
1999English

A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Duloxetine in Japanese Fibromyalgia Patients

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2015English

Prevalence of Comorbidities With Peanut Allergy: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Eptinezumab in Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study (PROMISE-1)

Cephalalgia
MedicineNeurology
2020English

ADHD and EEG-neurofeedback: A Double-Blind Randomized Placebo-Controlled Feasibility Study

Journal of Neural Transmission
PsychiatryMental HealthNeurologyBiological Psychiatry
2010English

A Randomized, Placebo-Controlled, Double-Blind Trial of Sertraline for Postpartum Depression

Psychopharmacology
Pharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy